Network pharmacology and experiments in vivo and in vitro reveal that the Jia-Wei-Bu-Shen-Yi-Qi formula (JWBSYQF) and its active ingredient baicalein ameliorate BLM-induced lung fibrosis in mice via PI3K/Akt signaling pathway

Amberger, 2015, OMIM.org: online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders, Nucleic Acids Res., 43, D789, 10.1093/nar/gku1205 Berman, 2000, The protein data bank, Nucleic Acids Res., 28, 235, 10.1093/nar/28.1.235 Chen, 2002, TTD: therapeutic target database, Nucleic Acids Res., 30, 412, 10.1093/nar/30.1.412 2015, UniProt: a hub for protein information, Nucleic Acids Res., 43, D204, 10.1093/nar/gku989 Daina, 2019, SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules, Nucleic Acids Res., 47, W357, 10.1093/nar/gkz382 Della Latta, 2015, Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions, Pharmacol. Res., 97, 122, 10.1016/j.phrs.2015.04.012 Distler, 2019, Nintedanib for systemic sclerosis-associated interstitial lung disease, N. Engl. J. Med., 380, 2518, 10.1056/NEJMoa1903076 Du, 2021, Icariin attenuates bleomycin-induced pulmonary fibrosis by targeting Hippo/YAP pathway, Biomed. Pharmacother., 143, 10.1016/j.biopha.2021.112152 Gong, 2014, Inhibition of airway epithelial-to-mesenchymal transition and fibrosis by kaempferol in endotoxin-induced epithelial cells and ovalbumin-sensitized mice, Lab. Invest., 94, 297, 10.1038/labinvest.2013.137 Gross, 2001, Idiopathic pulmonary fibrosis, N. Engl. J. Med., 345, 517, 10.1056/NEJMra003200 Hewlett, 2018, Idiopathic pulmonary fibrosis: epithelial-mesenchymal interactions and emerging therapeutic targets, Matrix Biol., 71–72, 112, 10.1016/j.matbio.2018.03.021 Huang, 2021, Modified BuShenYiQi formula alleviates experimental allergic asthma in mice by negative regulation of type 2 innate lymphoid cells and CD4+ type 9 helper T cells and the VIP-VPAC2 signalling pathway, Pharm. Biol., 59, 1216, 10.1080/13880209.2021.1970198 Kim, 2015, Pirfenidone: a review of its use in idiopathic pulmonary fibrosis, Drugs, 75, 219, 10.1007/s40265-015-0350-9 Kong, 2020, Efficacy and safety of Jia Wei Bushen Yiqi formulas as an adjunct therapy to systemic glucocorticoids on acute exacerbation of COPD: study protocol for a randomized, double-blinded, multi-center, placebo-controlled clinical trial, Trials, 21, 760, 10.1186/s13063-020-04669-5 Li, 2020, Traditional Chinese medicine for the treatment of pulmonary fibrosis: a protocol for systematic review and meta-analysis of overview, Medicine (Baltim.), 99 Liu, 2017, Idiopathic pulmonary fibrosis: current status, recent progress, and emerging targets, J. Med. Chem., 60, 527, 10.1021/acs.jmedchem.6b00935 Luo, 2017, Signaling cross talk between TGF-β/smad and other signaling pathways, Cold Spring Harbor Perspect. Biol., 9, a022137, 10.1101/cshperspect.a022137 Moeller, 2008, The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?, Int. J. Biochem. Cell Biol., 40, 362, 10.1016/j.biocel.2007.08.011 Morris, 2009, AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility, J. Comput. Chem., 30, 2785, 10.1002/jcc.21256 Muhammad, 2018, Network pharmacology: exploring the Resources and methodologies, Curr. Top. Med. Chem., 18, 949, 10.2174/1568026618666180330141351 Nogales, 2022, Network pharmacology: curing causal mechanisms instead of treating symptoms, Trends Pharmacol. Sci., 43, 136, 10.1016/j.tips.2021.11.004 Otasek, 2019, Cytoscape Automation: empowering workflow-based network analysis, Genome Biol., 20, 185, 10.1186/s13059-019-1758-4 Park, 2019, Effects of β-sitosterol from corn silk on TGF-β1-induced epithelial-mesenchymal transition in lung alveolar epithelial cells, J. Agric. Food Chem., 67, 9789, 10.1021/acs.jafc.9b02730 Piñero, 2017, DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants, Nucleic Acids Res., 45, D833, 10.1093/nar/gkw943 Qin, 2022, Proteomics analysis reveals suppression of IL-17 signaling pathways contributed to the therapeutic effects of Jia-Wei Bu-Shen-Yi-Qi formula in a murine asthma model, Phytomedicine, 95, 10.1016/j.phymed.2021.153803 Rebhan, 1997, GeneCards: integrating information about genes, proteins and diseases, Trends Genet., 13, 163, 10.1016/S0168-9525(97)01103-7 Richeldi, 2017, Idiopathic pulmonary fibrosis, Lancet, 389, 1941, 10.1016/S0140-6736(17)30866-8 Ru, 2014, TCMSP: a database of systems pharmacology for drug discovery from herbal medicines, J. Cheminf., 6, 13, 10.1186/1758-2946-6-13 Schafer, 2017, Cellular senescence mediates fibrotic pulmonary disease, Nat. Commun., 8, 10.1038/ncomms14532 Seeliger, 2010, Ligand docking and binding site analysis with PyMOL and Autodock/Vina, J. Comput. Aided Mol. Des., 24, 417, 10.1007/s10822-010-9352-6 Spagnolo, 2021, Idiopathic pulmonary fibrosis: disease mechanisms and drug development, Pharmacol. Ther., 222, 10.1016/j.pharmthera.2020.107798 Sun, 2020, Baicalein alleviated TGF β1-induced type I collagen production in lung fibroblasts via downregulation of connective tissue growth factor, Biomed. Pharmacother., 131, 10.1016/j.biopha.2020.110744 Szklarczyk, 2021, The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets, Nucleic Acids Res., 49, D605, 10.1093/nar/gkaa1074 Tang, 2015, CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks, Biosystems, 127, 67, 10.1016/j.biosystems.2014.11.005 Thannickal, 2004, Mechanisms of pulmonary fibrosis, Annu. Rev. Med., 55, 395, 10.1146/annurev.med.55.091902.103810 Wang, 2017, PubChem BioAssay: 2017 update, Nucleic Acids Res., 45, D955, 10.1093/nar/gkw1118 Wishart, 2018, DrugBank 5.0: a major update to the DrugBank database for 2018, Nucleic Acids Res., 46, D1074, 10.1093/nar/gkx1037 Wolters, 2014, Pathogenesis of idiopathic pulmonary fibrosis, Annu. Rev. Pathol., 9, 157, 10.1146/annurev-pathol-012513-104706 Wolters, 2018, Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?, Lancet Respir. Med., 6, 154, 10.1016/S2213-2600(18)30007-9 Xia, 2020, Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19, Cell Prolif., 53, 10.1111/cpr.12949 Yang, 2019, Emerging role of PI3K/AKT in tumor-related epigenetic regulation, Semin. Cancer Biol., 59, 112, 10.1016/j.semcancer.2019.04.001 Yuan, 2017, How can synergism of traditional medicines benefit from network pharmacology?, Molecules, 22, 1135, 10.3390/molecules22071135 Zhang, 2009, Non-Smad pathways in TGF-beta signaling, Cell Res., 19, 128, 10.1038/cr.2008.328 Zhang, 2013, Signaling interplay between transforming growth factor-β receptor and PI3K/AKT pathways in cancer, Trends Biochem. Sci., 38, 612, 10.1016/j.tibs.2013.10.001 Zhou, 2019, Metascape provides a biologist-oriented resource for the analysis of systems-level datasets, Nat. Commun., 10, 1523, 10.1038/s41467-019-09234-6